Pure Global
NCT05477485

Antiretroviral Improvement Among Medicaid Enrollees

Antiretroviral Improvement Among Medicaid Enrollees (AIMS): An Insurance-based Data to Care Initiative for Medicaid Enrollees in Virginia
Virginia Commonwealth University·ClinicalTrials.gov·behavioralNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Human Immunodeficiency Virus
Drug/Device/Intervention
Antiretroviral Improvement among Medicaid enrolleeS (patient)
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Virginia Commonwealth University
Location
Richmond, United States of America
Timeline & enrollment
Phase
N/A
Start date
Nov 01, 2022
End date
May 01, 2024
Enrollment
1040 participants
Primary outcome

HIV viral load

Summary

This study will evaluate whether a new program will affect how often human immunodeficiency
 virus (HIV) antiretroviral therapy (ART) prescriptions are filled and whether the program
 improves the health of people living with HIV.

ICD-10 classifications
Human immunodeficiency virus [HIV] diseaseUnspecified human immunodeficiency virus [HIV] diseaseHuman immunodeficiency virus [HIV] disease resulting in other conditionsHuman immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseasesAsymptomatic human immunodeficiency virus [HIV] infection status
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05477485
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05477485 through Pure Global AI's free database. This phase not specified trial is sponsored by Virginia Commonwealth University and is currently Not yet recruiting. The study focuses on Human Immunodeficiency Virus. Target enrollment is 1040 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.